FDA Approved: BRILINTA — Original Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

FDA approved Brilinta (ticagrelor) through an original application for use in patients with acute coronary syndrome to reduce the risk of cardiovascular death, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction
• Stroke

Drugs mentioned

• BRILINTA (ticagrelor)

Snippet

ORIG AP for BRILINTA (TICAGRELOR)